Cyclin dependent kinase inhibitors differentially modulate synergistic cytokine responsiveness of hematopoietic progenitor cells

Stem Cells and Development

Volumn 21, Issue 10, 2012, Pages 1597-1603

  Broxmeyer, Hal E ^a   Franklin, David S ^b   Cooper, Scott ^a   Hangoc, Giao ^a   Mantel, Charlie ^a  

^a INDIANA UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL INTERACTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; GENE; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; MOUSE; NONHUMAN; P18 GENE; P21 GENE; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE PROGENITOR CELLS; HEMATOPOIETIC STEM CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; S PHASE; SPLEEN; STEM CELL FACTOR;

MUS;

EID: 84862852759     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0476     Document Type: Article

References (29)

1. Steinman RA. (2002). Cell cycle regulators and hematopoiesis. Oncogene 21:3403-3413.
2. Shaheen M and HE Broxmeyer. (2009). The humoral regulation of hematopoiesis. In: Hematology: Basic Principles and Practice, 5th edition. R Hoffman, EJ Benz Jr., SJ Shattil, B Furie, LE Silberstein, P McGlave, H Heslop and J Anastasi, eds. Elsevier Churchill Livingston, Philadelphia, PA. Part III, Chapter 24, pp 253-275.
3. Mantel C, Z Luo, J Canfield, S Braun, C Deng and HE Broxmeyer. (1996). Involvement of p21cip-1 and p27kip-1 in the molecular mechanisms of steel factor-induced proliferative synergy in vitro and of p21cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 88:3710-3719.
4. Braun SE, C Mantel, M Rosenthal, S Cooper, L Liu, KA Robertson, R Hromas and HE Broxmeyer. (1998). A positive effect of p21cip1/waf1 in the colony formation from murine myeloid progenitor cells as assessed by retroviral-mediated gene transfer. Blood Cells Mol Dis 24:138-148.
5. Mantel C, SE Braun, S Reid, O Henegariu, L Liu, G Hangoc and HE Broxmeyer. (1999). p21(cip-1/waf-1) deficiency causes deformed nuclear architecture, centriole overduplication, polyploidy, and relaxed microtubule damage checkpoints in human hematopoietic cells. Blood 93: 1390-1398.
6. Taniguchi T, H Endo, N Chikatsu, K Uchimaru, S Asano, T Fujita, T Nakahata and T Motokura. (1999). Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 93:4167-4178.
7. Cheng T, N Rodrigues, H Shen, Y Yang, D Dombkowski, M Sykes and DT Scadden. (2000). Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287: 1804-1808.
8. Fero ML, M Rivkin, M Tasch, P Porter, CE Carow, E Firpo, K Polyak, LH Tsai, V Broudy, et al. (1996). A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744.
9. Cheng T, N Rodrigues, D Dombkowski, S Stier and DT Scadden. (2000). Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med 6:1235-1240.
10. Walkley CR, ML Fero, WM Chien, LE Purton and GA McArthur. (2005). Negative cell-cycle regulators cooperatively control self-renewal and differentiation of haematopoietic stem cells. Nat Cell Biol 7:172-178.
11. Yuan Y, H Shen, DS Franklin, DT Scadden and T Cheng. (2004). In vivo self-renewing divisions of haematopoietic stem cells are increased in the absence of the early G1-phase inhibitor, p18INK4C. Nat Cell Biol 6:436-442.
12. Yu H, Y Yuan, H Shen and T Cheng. (2006). Hematopoietic stem cell exhaustion impacted by p18 INK4C and p21 Cip1/Waf1 in opposite manners. Blood 107:1200-1206.
13. van OR, LM Kamminga, A Ausema, LV Bystrykh, DP Draijer, PK van, B Dontje and HG de. (2007). A Limited role for p21Cip1/Waf1 in maintaining normal hematopoietic stem cell functioning. Stem Cells 25:836-843.
14. Franklin DS, VL Godfrey, DA O'Brien, C Deng and Y Xiong. (2000). Functional collaboration between different cyclindependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 20:6147-6158.
15. Franklin DS, VL Godfrey, H Lee, GI Kovalev, R Schoonhoven, S Chen-Kiang, L Su and Y Xiong. (1998). CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12:2899-2911.
16. Christopherson KW, G Hangoc, CR Mantel and HE Broxmeyer. (2004). Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 305:1000-1003.
17. Broxmeyer HE, CM Orschell, DW Clapp, G Hangoc, S Cooper, PA Plett, WC Liles, X Li, B Graham-Evans, et al. (2005). Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201:1307-1318.
18. Cooper S and HE Broxmeyer. (1996). Measurement of interleukin-3 and other hematopoietic growth factors, such as GM-CSF, G-CSF, M-CSF, erythropoietin and the potent costimulating cytokines steel factor and Flt-3 ligand. In: Current Protocols in Immunology. JE Coligan, AM Kruisbeek, DH Margulies, EM Shevach, W Strober and R Coico, eds. John Wiley & Sons, Inc., New York, Suppl 18, pp 6.4.1-6.4.12.
19. Kim CH, CK Qu, G Hangoc, S Cooper, GS Feng and HE Broxmeyer. (1999). Abnormal chemokine-induced responses of immature and mature hematopoietic cells from motheaten mice implicates the protein tyrosine phosphatase SHP-1 in chemokine responses. J Exp Med 190:681-690.
20. Broxmeyer HE, BS Youn, CH Kim, G Hangoc, S Cooper and C Mantel. (2001). Chemokine regulation of hematopoiesis and the involvement of pertussis toxin-sensitive Gai proteins. NY Acad Sci 938:117-128.
21. Broxmeyer HE, S Cooper, L Lu, ME Miller, CD Langefeld and P Ralph. (1990). Enhanced stimulation of human bone marrow macrophage colony formation in vitro by recombinant human macrophage colony stimulatng factor in agarose medium at low oxygen tension. Blood 76:323-329.
22. Kovalev GI, DS Franklin, VM Coffield, Y Xiong and L Su. (2001). An important role of CDK inhibitor p18(INK4c) in modulating antigen receptor-mediated T cell proliferation. J Immunol 167:3285-3292.
23. Franklin DS and Y Xiong. (1996). Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell 7:1587-1599.
24. Damo LA, PW Snyder and DS Franklin. (2005). Tumorigenesis in p27/p53-and p18/p53-double null mice: functional collaboration between the pRb and p53 pathways. Mol Carcinog 42:109-120.
25. Dib A, TR Peterson, L Raducha-Grace, A Zingone, F Zhan, I Hanamura, B Barlogie, J Shaughnessy Jr. and WM Kuehl. (2006). Paradoxical expression of INK4c in proliferative multiple myeloma tumors: bi-allelic deletion vs increased expression. Cell Div 1:23.
26. Joshi PP, MV Kulkarni, BK Yu, KR Smith, DL Norton, VW van, JW Hoppener and DS Franklin. (2007). Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis. Oncogene 26:554-570.
27. van VW, CJ van Gasteren, DS Acton, DS Franklin, R Berger, CJ Lips and JW Hoppener. (2008). Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development. Cancer Res 68:1329-1337.
28. Kool J, AG Uren, CP Martins, D Sie, RJ de, G Turner, UM van, K Matentzoglu, W Lagcher, et al. (2010). Insertional mutagenesis in mice deficient for p15Ink4b, p16Ink4a, p21Cip1, and p27Kip1 reveals cancer gene interactions and correlations with tumor phenotypes. Cancer Res 70:520-531.
29. Venkataramani RN, TK MacLachlan, X Chai, WS El-Deiry and R Marmorstein. (2002). Structure-based design of p18INK4c proteins with increased thermodynamic stability and cell cycle inhibitory activity. J Biol Chem 277:48827-48833.